CLINICAL_TRIALS
trial_result
· 2017-07-31
Clinical Trial Update: Immunosuppression in Amyotrophic Lateral Sclerosis (ALS) [Phase 2]
Summary
This document reports the completion and results posting of a Phase 2 trial evaluating immunosuppression in amyotrophic lateral sclerosis (ALS).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Emory University | Conditions: Amyotrophic Lateral Sclerosis (ALS) | Phase 2 | Status: COMPLETED | Results posted: 2017-07-31